Analysis of the frequency of GNAS codon 201 mutations in advanced colorectal cancer

Cancer Genetics and Cytogenetics

Volumn 202, Issue 1, 2010, Pages 67-69

  Idziaszczyk, S ^a   Wilson, C H ^b   Smith, C G ^a   Adams, D J ^a   Cheadle, J P ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; CODON; GNAS PROTEIN, HUMAN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

CANCER TISSUE; CODON; COLORECTAL CANCER; CONTROLLED STUDY; DNA EXTRACTION; EXON; GENE ACTIVATION; HUMAN; HUMAN TISSUE; LETTER; MAJOR CLINICAL STUDY; MUTATION RATE; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SOMATIC MUTATION; TREATMENT RESPONSE; CELL DIVISION; COLORECTAL TUMOR; GENE FREQUENCY; GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY;

BASE SEQUENCE; CELL DIVISION; CODON; COLORECTAL NEOPLASMS; GENE FREQUENCY; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; MUTATION;

EID: 77956155312     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.04.023     Document Type: Letter

References (19)

1. Sjoblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314:268-274.
2. Wood L.D., Parsons D.W., Jones S., Lin J., Sjoblom T., Leary R.J., et al. The genomic landscapes of human breast and colorectal cancers. Science 2007, 318:1108-1113.
3. Parsons D.W., Jones S., Zhang X., Lin J.C., Leary R.J., Angenendt P., et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008, 321:1807-1812.
4. Jones S., Zhang X., Parsons D.W., Lin J.C., Leary R.J., Angenendt P., et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008, 321:1801-1806.
5. Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., et al. Patterns of somatic mutation in human cancer genomes. Nature 2007, 446:153-158.
6. Weinstein L.S., Liu J., Sakamoto A., Xie T., Chen M. Minireview: GNAS: normal and abnormal functions. Endocrinology 2004, 145:5459-5464.
7. Landis C.A., Masters S.B., Spada A., Pace A.M., Bourne H.R., Vallar L. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 1989, 340:692-696.
8. Taboada G.F., Tabet A.L., Naves L.A., de Carvalho D.P., Gadelha M.R. Prevalence of gsp oncogene in somatotropinomas and clinically non-functioning pituitary adenomas: our experience. Pituitary 2009, 12:165-169.
9. Hayward B.E., Barlier A., Korbonits M., Grossman A.B., Jacquet P., Enjalbert A., Bonthron D.T. Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly. J Clin Invest 2001, 107:R31-R36.
10. Palos-Paz F., Perez-Guerra O., Cameselle-Teijeiro J., Rueda-Chimeno C., Barreiro-Morandeira F., Lado-Abeal J., et al. Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain. Eur J Endocrinol 2008, 159:623-631.
11. Kalfa N., Lumbroso S., Boulle N., Guiter J., Soustelle L., Costa P., et al. Activating mutations of Gsalpha in kidney cancer. J Urol 2006, 176:891-895.
12. Fragoso M.C., Latronico A.C., Carvalho F.M., Zerbini M.C., Marcondes J.A., Araujo L.M., et al. Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors. J Clin Endocrinol Metab 1998, 83:2074-2078.
13. Bos J.L. Ras oncogenes in human cancer: a review. Cancer Res 1989, 49:4682-4689.
14. Brink M., de Goeij A.F., Weijenberg M.P., Roemen G.M., Lentjes M.H., Pachen M.M., et al. K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study. Carcinogenesis 2003, 24:703-710.
15. Braun M.S., Richman S.D., Quirke P., Daly C., Adlard J.W., Elliott F., et al. Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial. J Clin Oncol 2008, 26:2690-2698.
16. Wilson C.H., McIntyre R.E., Arends M.J., Adams D.J. The activating mutation R201C in GNAS promotes intestinal tumourigenesis in ApcMin/+ mice via activation of Wnt and ERK1/2 MAPK pathways. Oncogene 2010, (in press).
17. MacMahon H.E. Albright's syndrome-thirty years later (polyostotic fibrous dysplasia). Pathol Ann 1971, 6:81-146.
18. Weinstein L.S., Shenker A., Gejman P.V., Merino M.J., Friedman E., Spiegel A.M. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991, 325:1688-1695.
19. Siegel R.L., Jemal A., Ward E.M. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev 2009, 18:1695-1698.